A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
OConnor, Timothy, Ph.D. Laboratory Bookmark and Share

Laboratory of Timothy OConnor, Ph.D.

DNA repair is a basic necessary function in all cells, and the mechanisms for repair or damage avoidance are evolutionarily conserved. Cells are constantly subjected to DNA damage from exogenous environmental sources, and also from endogenous oxidative metabolism. Our laboratory is interested in DNA repair mechanisms, the biological consequences of repair failure, and how DNA repair mechanisms can be used to control the epigenome of cells. A complete understanding of DNA repair pathways and the activities of DNA repair proteins can lead to the identification of cellular defects linked to cancer etiology or to targets for tumor therapy.
 
Another more recent area of interest for our laboratory is DNA repair in stem cells. Although stem cells hold great promise in human disease treatment, the DNA repair capabilities must be robust and the genetic stability of cells fully characterized before their use in any regenerative therapy.
 
To address these areas we employ both in vitro and in vivo models to examine:
 
DNA Repair
DNA in cells is constantly exposed to damage from both endogenous and exogenous sources. To remove damage and maintain genomic stability, cells have evolved DNA repair systems. The protein levels in these pathways are finely tuned, and DNA damage may induce production of DNA repair proteins. We study DNA damage and repair from several aspects. Our work involves the study of adducts, the repair enzymes involved in adduct removal, how a repair system functions to remove an adduct, how repair systems interact, and finally the response of cells to DNA damage. One system that we focus on is the base excision repair (BER) pathway replacing mismatched or modified bases in DNA. BER is one of the most important systems in the elimination of endogenous DNA damage. The goal of our research is to understand how DNA repair proteins function to eliminate deleterious adducts from DNA and maintain genomic stability. Our research is divided into several areas.

DNA Repair Enzymology
We have cloned and overproduced numerous DNA repair proteins, and our work in this area continues. We have used the homogeneous proteins to study their biochemical and enzymatic properties. DNA repair proteins are often associated in complexes to facilitate repair. We have recently identified an interaction between two DNA repair proteins involved in the initial steps of both the base and nucleotide excision repair pathways. This interaction could prove critical in directing repair along both pathways. We are currently developing other methods to study these protein-protein interactions.

Regulation of DNA Repair Genes
In response to DNA damage, DNA repair capacity can increase, decrease, or remain unchanged. We are now investigating the response of DNA repair genes to DNA damage at the mRNA, protein, and activity levels. Alteration of the levels of DNA repair proteins can result in a change in the efficiency of a given DNA repair system to remove adducts. This work will serve as the basis for predicting the outcome of different chemo- and radio-therapeutic treatments.

In vivo Repair of DNA Damage
In addition to the study of individual DNA repair enzymes, we are interested in how these enzymes function in cells to excise DNA damage. We are using genomic sequencing techniques, such as ligation-mediated polymerase chain reaction (LMPCR), to follow DNA repair in vivo. We have shown that the repair of methylated bases via BER at nucleotide resolution in normal human cells is heterogeneous and have identified sites of DNA repair footprints. Damage and repair at nucleotide resolution of bases damaged by oxidation and chemotherapeutic agents have also been studied. We are adapting this technique to study the effects of gene therapy agents on the function of DNA repair in human cells.
 
For more information on Dr. O'Connor, please click here.

OConnor, Timothy, Ph.D. Laboratory

Laboratory of Timothy OConnor, Ph.D.

DNA repair is a basic necessary function in all cells, and the mechanisms for repair or damage avoidance are evolutionarily conserved. Cells are constantly subjected to DNA damage from exogenous environmental sources, and also from endogenous oxidative metabolism. Our laboratory is interested in DNA repair mechanisms, the biological consequences of repair failure, and how DNA repair mechanisms can be used to control the epigenome of cells. A complete understanding of DNA repair pathways and the activities of DNA repair proteins can lead to the identification of cellular defects linked to cancer etiology or to targets for tumor therapy.
 
Another more recent area of interest for our laboratory is DNA repair in stem cells. Although stem cells hold great promise in human disease treatment, the DNA repair capabilities must be robust and the genetic stability of cells fully characterized before their use in any regenerative therapy.
 
To address these areas we employ both in vitro and in vivo models to examine:
 
DNA Repair
DNA in cells is constantly exposed to damage from both endogenous and exogenous sources. To remove damage and maintain genomic stability, cells have evolved DNA repair systems. The protein levels in these pathways are finely tuned, and DNA damage may induce production of DNA repair proteins. We study DNA damage and repair from several aspects. Our work involves the study of adducts, the repair enzymes involved in adduct removal, how a repair system functions to remove an adduct, how repair systems interact, and finally the response of cells to DNA damage. One system that we focus on is the base excision repair (BER) pathway replacing mismatched or modified bases in DNA. BER is one of the most important systems in the elimination of endogenous DNA damage. The goal of our research is to understand how DNA repair proteins function to eliminate deleterious adducts from DNA and maintain genomic stability. Our research is divided into several areas.

DNA Repair Enzymology
We have cloned and overproduced numerous DNA repair proteins, and our work in this area continues. We have used the homogeneous proteins to study their biochemical and enzymatic properties. DNA repair proteins are often associated in complexes to facilitate repair. We have recently identified an interaction between two DNA repair proteins involved in the initial steps of both the base and nucleotide excision repair pathways. This interaction could prove critical in directing repair along both pathways. We are currently developing other methods to study these protein-protein interactions.

Regulation of DNA Repair Genes
In response to DNA damage, DNA repair capacity can increase, decrease, or remain unchanged. We are now investigating the response of DNA repair genes to DNA damage at the mRNA, protein, and activity levels. Alteration of the levels of DNA repair proteins can result in a change in the efficiency of a given DNA repair system to remove adducts. This work will serve as the basis for predicting the outcome of different chemo- and radio-therapeutic treatments.

In vivo Repair of DNA Damage
In addition to the study of individual DNA repair enzymes, we are interested in how these enzymes function in cells to excise DNA damage. We are using genomic sequencing techniques, such as ligation-mediated polymerase chain reaction (LMPCR), to follow DNA repair in vivo. We have shown that the repair of methylated bases via BER at nucleotide resolution in normal human cells is heterogeneous and have identified sites of DNA repair footprints. Damage and repair at nucleotide resolution of bases damaged by oxidation and chemotherapeutic agents have also been studied. We are adapting this technique to study the effects of gene therapy agents on the function of DNA repair in human cells.
 
For more information on Dr. O'Connor, please click here.
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.

Learn more about
City of Hope's institutional distinctions, breakthrough innovations and collaborations.
 
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...